Glioneuronal Tumors.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic review methodology or original empirical data
PubMed 41274770 · doi:10.1016/j.nic.2025.08.004
What was done
This narrative review synthesizes current clinical and radiological knowledge on glioneuronal tumors in pediatric and young adult populations. The review focuses on central nervous system neuroimaging features—particularly conventional magnetic resonance imaging (MRI), perfusion MRI, and functional MRI—used for tumor diagnosis, differential diagnosis, surgical planning, and emerging integration with radiomics and molecular profiling.
What was found
The abstract reports no quantitative metrics, diagnostic accuracy numbers, or statistical comparisons. It summarizes that MRI is the primary diagnostic imaging modality, low-grade glioneuronal tumors typically have a favorable prognosis compared to high-grade variants, and advanced imaging along with molecular insights are influencing management strategies.
Why it matters
Glioneuronal tumors are rare central nervous system neoplasms where accurate preoperative differentiation and localization are critical for surgical and therapeutic planning in young patients.
Limits
As a narrative review, it does not employ systematic search methods, meta-analytic pooling, or new patient data. The abstract provides purely qualitative summaries without diagnostic test accuracy metrics (such as sensitivity or specificity) or comparative survival outcomes.
Cited by
- supports Primary brain tumors arise predominantly from glial cells rather than neurons, and cancer is extremely rare in mature neurons.